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Purpose:  To  evaluate  and  compare  the  toxicological  profiles  of  two  quaternary  ammonium  compounds  (QAC),
benzalkonium chloride (BAK), and cetalkonium chloride (CKC), in standard solution or cationic emulsion formulations
in rabbit eyes using newly developed in vivo and ex vivo experimental approaches.
Methods: Seventy eyes of 35 adult male New Zealand albino rabbits were used in this study. They were randomly divided
into five groups: 50 µl of phosphate-buffered saline (PBS), PBS containing 0.02% BAK or 0.002% CKC (BAK Sol and
CKC Sol, respectively), and emulsion containing 0.02% BAK or 0.002% CKC (BAK Em and CKC Em, respectively)
were applied to rabbit eyes 15 times at 5-min intervals. The ocular surface changes induced by these eye drops were
investigated using slit-lamp examination, flow cytometry (FCM), impression cytology (IC) on conjunctiva, and corneal
in vivo confocal microscopy (IVCM). Standard immunohistology in cryosections was also examined for cluster of
differentiation  (CD)  45+  infiltrating  and  terminal  deoxynucleotidyl  transferase-mediated  dUTP-nick  end  labeling
(TUNEL)+ apoptotic cells.
Results: Clinical observations and IVCM showed that the highest toxicity was induced by BAK Sol, characterized by
damaged corneal epithelium and a high level of inflammatory infiltration. BAK Em and CKC Sol presented moderate
effects, and CKC Em showed the lowest toxicity with results similar to those of PBS. Conjunctival imprints analyzed by
FCM showed a higher expression of RLA-DR and TNFR1 markers in BAK Sol-instilled eyes than in all other groups,
especially at 4 h. Immunohistology was correlated with in vivo and ex vivo findings and confirmed this toxicity profile.
A high level of infiltration of CD45+ inflammatory cells and TUNEL+ apoptotic cells was observed in limbus and
conjunctiva, especially in QAC solution-receiving eyes compared to QAC emulsion-instilled eyes.
Conclusions: The acute administration of 15 instillations at 5 min intervals was a rapid and efficient model to assess
quaternary ammonium toxicity profiles. This model showed the highest toxicity, induced by the BAK solution, and the
lowest level of toxicity, induced by the CKC emulsion. These in vivo and ex vivo experimental approaches demonstrated
that ocular surface toxicity was reduced by using an emulsion instead of a traditional solution and that a CKC emulsion
was safe for future ocular administration.
During the past few years, several oil-in-water emulsions
have been introduced on the market for the treatment of dry
eye syndrome and are used as tear substitutes or vehicles for
active compounds [1-4]. These oil-in-water emulsions can be
visualized as tiny oil droplets suspended within an aqueous
phase, and they are particularly suitable for dry eye syndromes
because of the oil supplementation to the tear film. Oil-in-
water emulsions can be charged positively (for example, the
surface  of  the  tiny  droplets  becomes  cationic)  by  adding
quaternary ammonium compounds (QACs) as cationic agents
[1,2,5].  This  cationic  emulsion  technology  presents  the
advantage of the electrostatic attraction between the positively
charged emulsion with the negatively charged ocular surface
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(cornea and conjunctiva), which allows longer residence time
and hence, an improved ocular bioavailability of the active
compound [1-5].
However, the use of QACs as cationic agents at relatively
high concentrations in emulsion raises concerns regarding
their  toxicological  profile.  As  the  most  commonly  used
preservative [6], benzalkonium chloride (BAK), has shown
its high level of toxicity in vitro and ex vivo by stimulating
epithelial cell death [7,8], acting as pro-inflammatory or pro-
apoptotic mediators [9], inducing oxidative stress [10-12], and
significantly altering the precorneal mucins [13]. In vivo,
these iatrogenic effects were most particularly found with the
eye drops used for treating long-term pathologies such as
glaucoma. The analysis of conjunctival epithelium using flow
cytometry (FCM) showed increased human leukocyte antigen
(HLA) DR class II antigens, interleukin (IL) synthesis such as
IL-6, IL-8, IL-10 [14], and the involvement of both T helper
(Th)1 and TH2 systems through the overexpression of CC
chemokine receptor (CCR) 5 and CCR4 in the conjunctiva of
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204long term-treated glaucomatous patients [15,16]. Moreover,
BAK-induced conjunctival fibrosis is considered a relevant
risk factor for glaucoma surgery failure [17].
Indeed, several papers have reported that the efficacy of
different  preservatives  including  BAK  is  attenuated  when
incorporated  within  an  oil-in-water  emulsion  [18-20].  In
emulsions, high concentrations of antimicrobial agents were
needed  to  achieve  effective  preservative  activity  [21].  In
emulsion, BAK partitioned preferentially in the oil phase,
resulting in only approximately 1.2% free BAK in solution in
the aqueous phase [22]. The antimicrobial activity and the
correlated  toxicity  are  driven  by  the  free  preservative  in
solution whereas the emulsion-bound preservative seems to
lose its efficacy.
BAK is composed of a mixture of alkylbenzyldimethyl
ammonium  chlorides  bearing  various  alkyl  chain  lengths,
each one with a different water solubility and water-octanol
partition coefficient [23,24]. For the development of cationic
emulsions in ophthalmology, the use of QAC for their cationic
property  rather  than  their  preservative  effect  is  being
considered. We suggested the use of lipophilic cetalkonium
chloride  (CKC),  one  of  the  longest  alkyl-chain  BAK
components, as a cationic agent in ophthalmic emulsions.
With a highly lipophilic QAC, the distribution between the oil
and aqueous phases of the emulsion is modified because of
the affinity toward the oil phase, further favoring the cationic
agent role over the preservative role.
It is important for further clinical developments to study
the toxicological profiles of these new BAK or CKC-cationic
emulsions and to compare them with solutions. Over the past
few years, our group has developed new in vivo tools to
explore the ocular surface of animal models. In vivo confocal
microscopy (IVCM) offers a high definition of histological-
like  images  that  correspond  very  well  with  standard
immunohistology of healthy and pathological conjunctivae or
corneas [25-28]. It can be used repeatedly in vivo to follow a
disease course or a healing process. Moreover, the evaluation
of impression cytology (IC) specimens with FCM has been
widely used to detect inflammation, apoptosis, or TH1/TH2
profiles in patients [14-16], in rabbit conjunctivitis, and in rat
ocular toxicity models [25,27,28]. Class II HLA-DR antigens
and tumor necrosis factor (TNF)-related markers were thus
found  to  be  involved  in  toxicological  or  inflammatory
pathways of the ocular surface [14-16,25].
In  this  study,  we  combined  two  new  investigative
methods (IVCM for in vivo tissues images and IC for ex vivo
epithelium inflammatory marker expression) in correlation
with  standard  immunohistology  for  deep  infiltration  and
apoptosis to assess the toxicological effects of BAK/CKC
emulsion/solution  formulations  on  the  ocular  surface  of
rabbits.  We  chose  an  experimental  model  described  by
Ichijima, consisting of 15 successive instillations in rabbit
eyes  at  5-min  intervals  [29].  This  model  presents  the
advantages of inducing a toxic injury in a relatively short time
and of emphasizing the effects of standard concentrations of
compounds in which its toxicity could only be assessed over
the  long-term  in  standard  instillation  conditions.  Our
objectives were to evaluate the interest of QAC-containing
emulsions  compared  to  QAC-containing  solutions,  to
compare BAK and CKC toxicity, and to assess the ocular
safety of the newly developed CKC cationic emulsion.
METHODS
Animals  and  eye  drop  treatments:  All  experiments  were
conducted in accordance with the ARVO Statement for the
Use of Animals in Ophthalmic and Vision Research. Male
albino rabbits (New Zealand; two to three kilogram) were
used. Before all experiments, the ocular surface integrity was
examined by slip-lamp microscopy. A mixture of ketamine
(35 mg/kg; Imalgène 500; Merial, Lyon, France) and xylazine
(5 mg/kg; Bayer, Puteaux, France) was used to anesthetize the
animals. Each group was composed of seven rabbits: five
rabbits  were  used  for  clinical  and  IVCM  observation,
conjunctival imprints collection at hour (H) 4, day (D) 1, D4,
and D7; two rabbits from each treatment were sacrificed for
immunohistological procedures at D1, a time point chosen for
the  maximal  inflammatory  infiltration  according  to  a
preliminary seven-day study (data not shown).
We instilled 50 µl eye drops of sterile phosphate-buffered
saline (PBS), 0.02% BAK solution (BAK Sol), 0.02% BAK
in emulsion (BAK Em), 0.002% CKC solution (CKC Sol), or
0.002% CKC in emulsion (CKC Em) in rabbit eyes 15 times
at 5 min intervals according to Ichijima et al. [29]. All the eye
drops were supplied by Novagali Pharma (Evry, France) and
were  sterile  with  physiologic  pH  and  osmolality.  We
compared 0.02% BAK to 0.002% CKC since these two QAC
concentrations  confer  equivalent  positive  charge  to  the
emulsion surface (zeta potential around 20 mV), and similarly
enhanced ocular delivery could be obtained with cyclosporine
A (CsA)-emulsions containing 0.002% CKC or 0.02% BAK
(data not shown).
Clinical findings and Draize test: The first instillation was
chosen as time zero (T0). During the instillations, the time
when conjunctival redness appeared was recorded. At H4, D1,
and D4, the eyes were examined using slit lamp microscopy
for ocular irritation and scored according to a weighted scale
for grading the severity of ocular lesions modified from the
Draize Test [25,26,28]. We especially evaluated the degree of
redness, swelling (chemosis), and tearing of the conjunctiva;
the  degree  and  area  of  cornea  opacity;  and  the  increased
prominence of folds and congestion of the iris. The possible
maximum total score was 110 (conjunctiva=20, cornea=80,
iris=10).
In vivo confocal microscopy observation and scale: The laser
scanning  IVCM  Heidelberg  Retina  Tomograph  (HRT)  II/
Rostock  Cornea  Module  (RCM;  Heidelberg  Engineering
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ocular surface [25-28]. The x-y position and the depth of the
optical section were controlled manually; the focus position
(µm) was automatically calculated by the HRT II/RCM. For
all eyes, at least 10 confocal microscopic images of each layer
in the conjunctiva/limbus/cornea were recorded and analyzed.
The final scores were the averages of the 10 eyes of five
animals.
An IVCM scale was established to quantify the ocular
surface damage as presented in Table 1 [28]. Scores were
obtained  for  five  zones:  the  superficial  epithelium,  basal
epithelium, and anterior stroma of the cornea, limbus, and
conjunctival  blood  vessels.  Cell  morphology  and  nuclear
aspects  were  evaluated,  and  the  number  of  infiltrating
inflammatory cells (lymphocytes, polymorphonuclear cells,
or dendritic-like cells) was assessed by using the Cell Count®
program (Heidelberg Engineering GmbH) associated with the
HRT II/RCM. The maximal score was 40.
Conjunctival impression cytology collection: IC specimens
were collected by techniques previously described [25,27,
28]. Two types of IC techniques were used for this study. Two
nitrocellulose  membranes  (Millipore,  Bedford,  MA)  were
applied to the superior bulbar conjunctiva and then dipped into
tubes  containing  1.5  ml  of  cold  PBS  with  4%
paraformaldehyde (PFA) for future cresyl violet cytology, and
two Supor®-membrane (Gelman Sciences, Ann Arbor, MI)
were  dipped  immediately  after  application  into  tubes
containing 1.5 ml of cold PBS with 0.05% PFA and kept at
4 °C until FCM procedures.
TABLE 1. IN VIVO CONFOCAL MICROSCOPY SCALE FOR THE EVALUATION OF OCULAR TOXICITY IN THE CORNEA, THE LIMBUS, AND THE CONJUNCTIVA
(MAXIMUM SCORE: 40)
Tissue Ocular surface damage IVCM scale
Property Grade
Superficial epithelium
(10)
DESQUAMATION Partial 2
Total important 4
SHAPE/SIZE anisocytosis, microcytosis,
macrocytosis, irregular
shape, edematous cells,
swollen cells, loss of cell
borders
2
REFLECTIVITY abnormal reflectivity
patterns: hyperreflective
cells, nuclei visible in
hyperreflective cells or not
2
INFLAMMATION presence of inflammatory
infiltration
2
Basal epithelium (10) DISORGANIZATION 2
INFLAMMATORY INFILTRATION 0>slight >100 cells/mm2 2
50>mild> 100 cells/mm2 4
100>moderate> 200 cells/mm2 6
severe> 200 cells/mm2 8
Anterior stroma (10) DISORGANIZATION 2
INFLAMMATORY INFILTRATION 0>slight >50 cells/mm2 2
50>mild > 100 cells/mm2 4
100>moderate> 200 cells/mm2 6
severe> 200 cells/mm2 8
Limbus and conjunctiva
(10)
PRESENCE OF CAPILLARY
BUD FROM LIMBAL VESSELS
(trend to neovascularization)
2
Presence of inflammatory
infiltrates, rolling in limbal
vessel / conjunctiva zone
0>slight >50 cells/mm2 2
50>mild> 100 cells/mm2 4
100> moderate > 200 cells/mm2 6
severe> 200 cells/mm2 8
In vivo confocal microscopy scale was obtained for five zones: the superficial epithelium, basal epithelium, and anterior stroma
of the cornea, limbus, and conjunctival blood vessels. Cell morphology and nuclear aspects were evaluated, and the number of
infiltrating inflammatory cells (lymphocytes, polymorphonuclear cells, or dendritic-like cells) was assessed.
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morphological  evaluation:  The  membranes  dipped  in  4%
PFA were washed in distilled water, dehydrated into ethanol,
and  stained  by  cresyl  violet  solution  (1%,  number  5235,
Merck, Fontenay-sous-Bois, France) for 30 min. The samples
were then air-dried and mounted in a Eukitt medium (CML,
Nemours, France).
We evaluated the morphology of the conjunctival ocular
surface according to a modified Nelson’s classification [30],
assessing the appearance of the epithelial cells (morphological
changes  in  the  cytoplasm  and  in  the  nucleus,  the
nucleocytoplasmic  (N/C)  ratio,  and  the  metachromatic
changes in the cytoplasm), inflammatory infiltration, and the
density of goblet cells and subsequently assigning the grades
to the ocular surface.
Figure  1.  Microphotographs  of  typical  clinical  features.
Microphotographs of typical clinical features of PBS- (A), BAK Sol-
(B), BAK Em- (C), CKC Sol- (D), and CKC Em- (E) instilled rabbit
eyes 4 h after repeated instillations are shown. BAK Sol induced
diffuse  hyperemia,  chemosis,  and  purulent  secretions  on  the
conjunctiva. BAK Em and CKC Sol also induced mild conjunctival
inflammation.  CKC  Em-receiving  eyes  presented  no  obvious
abnormality on the conjunctiva and showed nearly the same aspect
as the PBS-instilled eyes.
Figure 2. Draize test evaluation after PBS, BAK Sol, BAK Em, CKC
Sol, and CKC Em instillations in rabbit eyes at H4 and D1. The
asterisk indicates that p<0.01 compared to the PBS-instilled and
CKC Em-instilled groups; the sharp (hash mark) denotes that p<0.05
compared to the BAK Sol-instilled group.
Flow  cytometry  analysis  of  rabbit  impression  cytology
specimens: Conjunctival cells were extracted as previously
described [25,28]. Cells were extracted by gentle agitation and
were  analyzed  on  a  flow  cytometer  (FC500;  Beckman
Coulter, Miami, FL). A direct immunofluorescence procedure
was used to study the expressions of the class II antigen RLA
(rabbit  leukocyte  antigen)  DR  (1:40;  DakoCytomation,
Clostrup,  Denmark)  and  TNF-receptor  1  (mTNFR1,  1:40
dilution, R&D Systems, Minneapolis, MN). Mouse FITC-
conjugated IgG1 (BD Biosciences PharMingen, San Diego,
CA) was used as a negative control. For each antibody, a
minimum of 1,000 conjunctival cells were analyzed, and the
results were expressed as percentages of positive cells. Soon
after the FCM analysis, we stained the cell suspension with
propidium iodide (PI 0.5 µg/ml; Sigma Chemical Company,
St. Louis, MO). Immunoreactive cells were then spun down
on a glass slide using a cytospin centrifuge (Shandon Cytospin
4; Thermo, Electron Corporation, Waltham, MA) and later
observed  and  photographed  under  a  confocal  microscope
(E800; PCM 2000; Nikon, Tokyo, Japan).
Cryosections  and  immunohistology:  Two  rabbits  in  each
group were euthanized with a lethal dose of pentobarbital at
D1. Enucleated eyes were fixed in 4% PFA and embedded.
The  10  µm  cryosections  were  incubated  with  antibodies
directed  against  rabbit  CD45  (1:50;  CBL1412;  Cymbus
Biotechnology, Chandlers Ford, UK) to detect inflammatory
cell  infiltration.  Sections  were  stained  with  secondary
antibody and later with PI. To detect apoptotic cells, a terminal
deoxynucleotidyl  transferase-mediated  dUTP-nick  end
labeling  (TUNEL)  assay  (Roche  Diagnostics,  Meylan,
France) was used. Cryosections were first permeabilized and
then incubated with an apoptosis detection kit including the
10-μl TUNEL enzyme and 90-μlL TUNEL label at 37 °C for
1 h. After three washes in PBS, the slides were stained with
PI.
Images  were  digitized  using  an  Olympus  BX-UCB
fluorescent microscope (Olympus, Melville, NY) equipped
with a DP70 Olympus digital camera and image analysis
software. Positive cells to the different markers were counted
in a masked manner in four different rabbit eyes in at least five
areas.
Statistical  analysis:  Results  were  expressed  as  means
±standard error (SE). Draize and IVCM scores were compared
using  nonparametric  comparisons  (Mann–Whitney).  The
groups  for  analysis  in  IC  expression  with  FCM  and
immunopositive cells counts were compared using factorial
analysis  of  variance  (ANOVA)  followed  by  the  Fisher’s
method (Statview V; SAS Institute Inc., Cary, NC).
RESULTS
Clinical findings: Four hours after the first instillation (i.e.,
2.75  h  after  the  previous  one),  BAK  Sol  induced  diffuse
hyperemia,  chemosis,  and  purulent  secretions  on  the
Molecular Vision 2008; 14:204-216 <http://www.molvis.org/molvis/v14/a26> © 2008 Molecular Vision
207conjunctiva when compared with the PBS-instilled eye. BAK
Em and CKC Sol also induced mild conjunctival hyperemia
but less than what was induced by BAK Sol with no obvious
chemosis or purulent secretion (Figure 1). CKC Em-receiving
eyes (Figure 1E) presented no redness, chemosis, or secretions
on the conjunctiva and showed nearly the same aspect as the
PBS-instilled eyes.
PBS did not induce any redness during the instillation
period. BAK Sol induced conjunctival redness very quickly
13±1.07 min after the first instillation (p<0.0001 compared to
BAK Em and CKC Em). BAK Em and CKC Sol groups
started to show visible redness at 34±2.08 min and 23±3.50
min, respectively, with no significant difference between the
two groups. CKC Em induced a slight redness close to the end
of  the  experiment  60±4.47  min  after  the  first  instillation
(p<0.0001 compared to all other groups, except PBS).
Draize test: At H4, the BAK Sol-, BAK Em-, and CKC Sol-
instilled groups presented higher Draize Test scores than the
PBS-instilled group (p<0.01 for the three groups; Figure 2).
CKC  Em  presented  no  difference  with  the  PBS  group
(p>0.05). The ocular toxicity score was the highest in the BAK
Sol group (5±0.4), which had higher scores than the BAK Em
(2±0.4), CKC Sol (3±0.6), and CKC Em groups (0.4±0.3;
p<0.05 for the three groups). The BAK Em- and CKC Sol-
instilled groups also showed higher ocular toxicity than the
CKC Em-instilled group (p<0.01 for the two groups).
At D1, the PBS, BAK Em, CKC Sol, and CKC Em eyes
all returned to normal aspects without significant differences
among  them.  BAK  Sol  still  induced  substantial  ocular
Figure 3. HRT II IVCM images of rabbit ocular surface. HRT II IVCM images of rabbit ocular surface after PBS (A), BAK Sol (B), BAK
Em (C), CKC Sol (D), and CKC Em (E) instillations at D1 are displayed. Results are shown in the superficial epithelium (line 1), basal
epithelium (line 2: 10–15 μm from the superficial epithelium layer), anterior stroma (line 3: 50–65 μm from the superficial epithelium layer),
and conjunctival substantia propria (line 4: 60–90 μm from the superficial epithelium layer). BAK Sol-receiving eyes showed the greatest
damage in the epithelium and the greatest inflammatory infiltration in the basal epithelium and anterior corneal stroma. BAK Em and CKC
Sol induced intermediate toxicity. These three groups induced inflammatory cells rolling in conjunctival blood vessels. CKC Em presented
almost the same aspects in all ocular surface structures as the PBS-instilled group. The scale bar indicates 100 μm.
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groups,  p<0.05  compared  to  the  BAK  Em  and  CKC  Sol
groups). Only at D4 did the BAK Sol-instilled eyes return to
a normal ocular aspect (data not shown).
In vivo images of rabbit ocular surface after instillations:
Figure  3  shows  the  IVCM  images  of  the  rabbit  corneal
epithelium (line 1), basal epithelium (line 2), anterior stroma
(line 3), and conjunctival stroma (line 4) after application of
PBS (Figure 3A), BAK Sol (Figure 3B), BAK Em (Figure
3C), CKC Sol (Figure 3D), and CKC Em (Figure 3E) at D1.
Surface  epithelium—PBS-instilled  rabbits  presented
almost a normal corneal epithelium (Figure 3A) with a regular
polygonal mosaic appearance and brightly reflective nuclei.
No  obvious  desquamation,  swelling  of  epithelium,  or
inflammation was detected. BAK Sol (Figure 3B) induced
partial desquamation of epithelial cells. The cells presented
an irregular shape with abnormal reflectivity patterns and
swelling cells, observed as a loss of cell borders. Inflammatory
infiltrates  were  also  found.  Compared  to  the  BAK  Sol
instillation, fewer abnormalities were observed for BAK Em
(Figure 3C) and CKC Sol (Figure 3D) instillation with partial
desquamation of epithelial cells and irregular cell shapes. The
CKC Em group (Figure 3E) showed almost the same epithelial
aspects  as  did  PBS-instilled  rabbits  without  obvious
epithelium abnormality or inflammatory infiltration.
Basal  epithelium—PBS  (Figure  3A)  and  CKC  Em
(Figure 3E) induced no obvious inflammation in this layer
whereas BAK Sol (Figure 3B) induced the greatest infiltration
(129±13.29 inflammatory cells/mm2, p<0.001 compared to all
other  groups).  These  bright  hyperreflective  inflammatory
infiltrates were also found at a moderate level in the BAK Em-
instilled eyes (Figure 3C; 55±6.00 inflammatory cells/mm2,
p<0.001 compared to CKC Em) and in the CKC Sol-instilled
eyes (Figure 3D; 55±11.12 inflammatory cells/mm2, p<0.001
compared to CKC Em).
Figure  4.  In  vivo  confocal  microscopy  scores  in  the  five  tested
groups. The toxicity of CKC Em was less than that of BAK Sol, BAK
Em, and CKC Sol with no significant differences with the PBS-
instilled  groups  at  all  time  points  (H4,  D1,  and  D4).  BAK  Sol
presented  the  highest  IVCM  toxic  score  at  H4  on  D1  with
intermediate  results  for  BAK  Em  and  CKC  Sol.  The  asterisk
indicates that p<0.01 compared to PBS and CKC Em; the sharp (hash
mark) denotes that p<0.05 compared to BAK Sol; and the filled
diamond symbol indicates that p<0.05 compared to CKC Sol.
Anterior stroma—One day after instillation of BAK Sol
(Figure  3B),  slight  inflammatory  infiltration  and  slight
disorganization of the anterior stroma was recorded by IVCM.
No abnormality was observed in the anterior stroma in the
other groups (Figure 3A,C–E).
Posterior  stroma  and  endothelium—At  all  the
observation times, no abnormality was observed in any group
(data not shown).
Limbus—Minimal  inflammatory  cells  were  observed
after PBS and CKC Em instillations. In the BAK Sol-instilled
group, we observed that the inflammatory infiltrations in the
peripheral cornea and limbus area were more abundant than
in all the other groups (data not shown). We also observed the
presence of capillary buds from limbal vessels at this time.
Moderate inflammatory infiltration was also observed in the
BAK Em and CKC Sol groups.
Conjunctiva—Blood  vessels  in  hyperreflective
conjunctiva  were  observed  by  IVCM.  The  PBS-instilled
rabbit  presented  normal  conjunctival  blood  vessel  aspects
with no rolling inflammatory cells (Figure 3A). After the
applications of BAK Sol (Figure 3B), BAK Em (Figure 3C),
and CKC Sol (Figure 3D), inflammatory cells rolling along
vascular walls were consistently recorded in blood vessels. In
contrast, CKC Em-instilled eyes (Figure 3E) presented almost
normal blood vessel aspects as did PBS-instilled rabbits with
no obvious rolling cells. At H4 (images not shown), IVCM
showed the same tendency of toxic ranking with BAK Sol
inducing  the  worst  aspect  of  epithelium  and  the  greatest
inflammatory infiltration; BAK Em and CKC Sol induced
moderate abnormalities in cornea, limbus, and conjunctiva;
and the CKC Em group showed almost the same images as
did the PBS-instilled group. At D4 (images not shown), the
abnormalities found in the ocular surface decreased in all
groups.  BAK  Sol,  BAK  Em,  and  CKC  Sol  groups  still
presented abnormal aspects in limbus and conjunctival blood
vessels. These slight abnormalities disappeared at D7 after
instillations  (data  not  shown).  According  to  the  IVCM
observations,  the  CKC  Em-instilled  eyes  presented  no
difference in the ocular surface compared to PBS-instilled
eyes from H4 to the end of experiment.
In  vivo  confocal  microscopy  scale  evaluation:  An  IVCM
scoring system was used to quantify toxic patterns. As shown
in Figure 4, at H4 and D1, BAK Sol induced the highest IVCM
score compared to PBS, CKC Em (p<0.01 compared to the
two groups), BAK Em, and CKC Sol (p<0.05 compared to the
two groups). At these time points, the BAK Em- and CKC
Sol-instilled groups showed higher IVCM scores than did the
PBS-  and  CKC  Em-instilled  groups  (p<0.01  for  the  two
groups). BAK Em eyes presented lower IVCM scores than did
CKC Sol eyes (p<0.05) at H4 and D1. At H4, D1, and D4, the
CKC  Em-instilled  group  always  presented  similar  IVCM
scores  to  the  PBS-instilled  group  with  no  statistical
differences.  At  D4,  scores  decreased  for  every  treatment
except BAK Sol; BAK Em and CKC Sol still presented higher
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CKC Em (p<0.01 for the three groups) groups. At D7, the
IVCM scores of BAK Sol, BAK Em, and CKC Sol eyes
returned to normal aspects (data not shown).
Impression  cytology  staining:  Impression  cytology  of
conjunctival  surface  after  PBS  instillation  at  D1  showed
normal, polyedric conjunctival epithelial cells (Figure 5A)
with  a  prominent  nucleus.  The  nuclear  cytoplasmic  ratio
ranged  from  1/2  to  1/3.  There  were  no  inflammatory
infiltrating cells. The goblet cells were clearly visible among
or beside the epithelial cells. In the BAK Sol-instilled group
(Figure  5B),  the  conjunctival  epithelium  was  barely
recognized  because  of  the  very  intense  infiltration  of
polymorphonuclear  cells.  Goblet  cells  completely
disappeared after BAK Sol treatment at this time. The lesions
observed in conjunctival IC after cresyl violet staining are
summarized in Table 2. BAK Em (Figure 5C) and CKC Sol
(Figure  5D)  induced  moderate  toxicity  in  conjunctival
epithelium,  which  showed  aspects  of  anisocytosis  and
anisonucleosis. Inflammatory infiltration was observed, and
the  density  of  goblet  cells  decreased  after  these  two
treatments. The CKC Em eyes (Figure 5E) presented a nearly
normal  conjunctival  epithelium  aspect  with  no  obvious
inflammatory infiltration. Goblet cells were clearly present
with no morphological abnormalities.
Expression of rabbit leukocyte antigen (RLA) DR and tumor
necrosis factor receptor type 1 (TNFR1) evaluated by flow
cytometry: The baseline range of RLA DR- and TNFR1-
positive  cells  in  IC  specimens  from  normal  rabbits  was
approximately 3% - 6%. At H4, BAK Sol induced 65.4%
±4.7% of cells positive for RLA DR (Figure 6A). These were
mostly  inflammatory  cells  (Figure  6B)  as  viewed  after
cytospin centrifugation. The RLA DR expression in the other
groups was much lower than that of BAK Sol group with
statistical significance (p<0.0001 compared to PBS, BAK
Em, CKC Sol, and CKC Em groups). This high level of
expression decreased one day after instillation; BAK Sol still
induced  29.6%±3.7%  of  RLA  DR-positive  cells  with
significant  differences  with  the  other  groups  that  showed
normal levels (p<0.05 compared to the four other groups). At
D4,  RLA  DR-positive  cells  returned  to  the  normal  level
(approximately 5%) after BAK Sol instillation.
TNFR1 was also found at high levels at H4 after the
instillation of BAK Sol (Figure 6C; 44.3%±5.9% of positive
cells;  p<0.0001  compared  to  all  other  groups).  The  cells
positive to TNFR1 were mostly inflammatory cells as well as
some typical conjunctival epithelial cells (Figure 6D). At D1,
this strong expression of TNFR1-positive cells decreased to
18.2%±7.1%, which was still much higher than in the other
groups (p<0.05 compared to all other groups). At D4, this
expression returned to about 4% with no difference with all
other groups.
Immunostaining  of  CD45  and  terminal  deoxynucleotidyl
transferase-mediated  dUTP-nick  end  labeling  markers  in
cryosections: Immunostaining of CD45+ inflammatory cells
(line  1  for  limbus,  line  2  for  conjunctiva)  and  TUNEL+
Figure 5. Conjunctival impression cytology stained by cresyl violet at D1. PBS (A) presented normal aspects of the conjunctival epithelium
with no inflammatory infiltration. BAK Sol (B) induced numerous polymorphonuclear inflammatory cells with almost no normally shaped
epithelial cell visible. BAK Em (C) and CKC Sol (D) both showed epithelial damage with inflammatory infiltration. CKC Em-instilled (E)
rabbit eyes presented normal epithelial patterns without inflammatory infiltration. (original size 40×).
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210apoptotic cells (line 3 for limbus, line 4 for conjunctiva) at D1
are shown in Figure 7. The immunopositive cell counts are
presented in Figure 8. PBS-instilled rabbits only showed a few
CD45+ inflammatory cells in the limbus (Figure 7A; 180±43
cells/mm2) and conjunctiva (Figure 7A; 431±63 cells/mm2)
zones.  Immunohistology  clearly  showed  that  BAK  Sol
instillation  induced  numerous  CD45+  inflammatory  cells
infiltrating the limbus (Figure 7B) and conjunctiva (Figure
7B) zones, 1160±134 cells/mm2 and 1290±139 cells/mm2,
respectively (Figure 8A, p<0.005 compared to the PBS and
CKC Em groups). These inflammatory cells were especially
located in the limbal or conjunctival stroma but also beneath
the  epithelial  layers.  BAK  Em  presented  moderate
inflammatory infiltration, 900±121 cells/mm2 in the limbus
(Figure 7C) and 860±34 cells/mm2 in the conjunctiva (Figure
7C; p<0.005 compared to PBS; and p<0.05 compared to CKC
Em). BAK Em induced significantly fewer CD45+ cells than
did BAK Sol (p<0.005). CKC Sol also presented moderate
inflammatory infiltration (Figure 7D for limbus with 790±59
cells/mm2;  Figure  7D  for  conjunctiva  with  890±60  cells/
mm2; p<0.005 compared to PBS and p<0.05 compared to
CKC Em) with no difference with BAK Em treatment. After
CKC  Em  instillation,  occasional  inflammatory  cells  were
found in the limbal zone (Figure 7E, 170±40 cells/mm2) and
beneath the conjunctival epithelium (Figure 7E, 460±34 cells/
mm2) with no difference with the PBS group. In corneal tissue,
very slight CD45+ expression was found in the BAK Sol-
instilled group, and no other treatments induced inflammatory
cells in the cornea (data not shown). Few apoptotic cells were
observed in the limbal zone (Figure 7A, 110±38 cells/mm2)
and in the conjunctiva (Figure 7A, 280±53 cells/mm2) after
instillation of PBS. When BAK Sol was instilled in the ocular
TABLE 2. DESCRIPTION OF CRESYL VIOLET CONJUNCTIVAL IMPRESSION CYTOLOGY RESULTS AT D1 FOLLOWING REPEATED APPLICATIONS OF
QUATERNARY AMMONIUM COMPOUND EMULSIONS AND SOLUTIONS
PBS BAK Sol BAK Em CKC Sol CKC Em
Nucleocytoplasmic
ratio
1/2 to 1/3 Not interpretable due to inflammation 1 to 1/2 1 to 1/2 1/2 to 1/3
Anisocytosis/
anisonucleosis
/ ++++ ++ ++ +
Cell size Normal Very irregular Irregular Irregular Normal
Inflammatory cells / ++++ +++ ++ /
Goblet cells ++ / + + +++
Impression cytology of conjunctival surface after PBS instillation at D1 showed normal conjunctival epithelial cells without
inflammatory infiltration. In the BAK Sol-instilled group, there existed intense infiltration of polymorphonuclear cells. The
conjunctival epithelium and the goblet cells were barely recognized. BAK Em and CKC Sol induced moderate abnormality.
The CKC Em eyes presented an almost normal conjunctival epithelium aspect without obvious inflammatory infiltration. Goblet
cells were found to be normal. /: No abnormality, +: discrete, ++: moderate, +++: high, ++++: extremely intense
Figure 6. Impression cytology evaluated
by  flow  cytometry  and  viewed  after
cytospin centrifugation. Percentages of
RLA-DR- (A) and TNFR1- (C) positive
cells after multiple instillations of PBS,
BAK Sol, BAK Em, CKC Sol, CKC Em
is displayed. The astersisk indicates that
p<0.0001  compared  with  PBS,  BAK
Em, CKC Sol, and CKC Em-instilled
groups, and the doube asterisk means
that p<0.05 compared with PBS, BAK
Em, CKC Sol, and CKC Em-instilled
groups.  Positive  cells  for  RLA-DR
(green, B) and TNFR1 (green, D) were
viewed after propidium iodide staining
(red) and cytospin centrifugation. The
scale bar indicates 100 μm.
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211surface of rabbits, numerous apoptotic cells were found in the
limbal zone (Figure 7B and Figure 8B, 710±82 cells/mm2) and
conjunctiva  (Figure  7B,  820±80  cells/mm2;  p<0.005
compared to the PBS and CKC Em groups). Compared to
BAK Sol, the BAK Em treatment induced fewer apoptotic
cells  in  the  limbal  zone  (Figure  7C,  370±47  cells/mm2,
p<0.005 compared to the PBS and BAK Sol groups, p<0.05
compared  to  the  CKC  Em  group)  and  in  the  conjunctiva
(Figure 7C, 390±43 cells/mm2; p<0.005 compared to BAK
Sol  with  no  differences  with  PBS  or  CKC  Em-instilled
groups). Apoptosis was found in the limbal zone after CKC
Sol  application  (Figure  7D,  440±69  cells/mm2);  the
conjunctival stroma also contained numerous apoptotic cells
in subepithelial and deeper zones (Figure 7D, 590±41 cells/
mm2; p<0.005 compared to the PBS and BAK Sol groups;
p<0.05 compared to the CKC Em group). CKC Em induced
fewer apoptotic cells in the limbal (Figure 7E, 190±35 cells/
mm2) and conjunctival zones (Figure 7E, 250±48 cells/mm2)
with no difference compared to PBS. In corneal tissue, few
apoptotic cells were found in the superior epithelium of the
cornea after BAK Sol and CKC Sol instillations. In other
treatments, no apoptotic cells were found in the corneal layers
(data not shown).
DISCUSSION
Lipid  emulsions  are  known  to  improve  the  tolerance  of
topically applied ophthalmic drugs. Amphotericin B emulsion
was found to be better tolerated than the commercial solution
of Fungizone® in rabbits [31]. Several clinical studies of
emulsion-based eye drops of artificial tears or cyclosporine
showed good overall safety, efficacy, and comfort in normal
subjects and dry eye patients [3,4,32,33]. Compared to other
ophthalmic vectors, cationic vehicles have a better spreading
capacity  and  improve  ocular  bioavailability  [34-37].
Figure 7. Immunostaining of inflammatory (CD45) and apoptotic (TUNEL) markers in cryosections. Immunostaining of inflammatory (CD45
in green: line 1 limbus, line 2 conjunctiva) and apoptotic (TUNEL in green: line 3 limbus, line 4 conjunctiva) markers in cryosections of rabbit
eyes instilled with PBS (A), BAK Sol (B), BAK Em (C), CKC Sol (D), and CKC Em (E) at D1 is shown. Nuclei were stained in red with
propidium iodide. The scale bars indicate 100 μm. Immunohistology clearly showed that BAK Sol instillation induced numerous CD45+
inflammatory cells and TUNEL+ apoptotic cells infiltrating the limbus and conjunctiva zones. BAK Em and CKC Sol also induced moderate
inflammatory/apoptotic cells. After CKC Em or PBS instillation, occasional inflammatory/apoptotic cells were found.
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212Formulation of cyclosporine A in a cationic emulsion results
in significantly improved (11 fold) corneal and conjunctival
delivery in rabbits compared to olive oil [34]. Compared with
the  anionic  emulsion,  indomethacin  in  cationic  emulsion
provided  significantly  higher  drug  levels  in  the  aqueous
humor and sclera or retina [35], and submicron cationic lipid
emulsion enhanced the ocular bioavailability of cyclosporine
A  [36].  The  main  mechanism  involved  is  that  cationic
emulsions interact with the negatively charged ocular surface
such as the cell membranes of the conjunctival and corneal
epithelia.  In  an  effort  to  optimize  cationic  emulsions,  we
proposed the use of QAC to provide the cationic charge. BAK
cationic emulsion of cyclosporine significantly improved the
penetration  of  cyclosporine  over  a  negatively  charged
emulsion [4]. The use of lipophilic QAC, such as CKC rather
than BAK, allows obtaining a positive charge with a lower
amount of QAC because of its optimal oil/aqueous interface
distribution. In the present study, we studied the toxicity of
BAK  and  CKC  cationic  emulsions  compared  with  their
respective  BAK  and  CKC  solutions,  and  we  observed  a
reduction of QAC toxicity when it was incorporated into the
emulsion.
The model consisting of repeated applications in rabbit
eyes (15 times at 5 min intervals) does not reflect the real
ocular surface reactions in patients, but it may emphasize the
action  of  low  toxic  compounds  and  mimic  repeated
administrations. As the repetition of instillations in a short
period of time causes drastic stimulation of the ocular surface,
this model is useful for between-drug comparisons and testing
a specific compound’s absence of toxic effects, which is a
good indicator of further absence of ocular toxicity in a more
conventional use over the long-term. This model combined
rapidity and efficiency in comparing the toxicity of several
products  without  modifying  their  concentration  and/or
composition. It was therefore used in the past to distinguish
the toxicity ranking after applications of 0.02%, 0.01%, and
0.005%  BAK  and  clearly  showed  the  different  levels  of
epithelial deterioration [29]. In our study, this model also
clearly demonstrated the differences between emulsion and
solution formulations. Pertinent and reliable animal models
are  in  great  need  for  testing  new  formulations  and  new
preservatives.  To  simulate  long-term  toxicity  of  QAC  at
reasonable time intervals and over a short period of time,
previous studies have used high concentrations (50 fold to 500
fold the commercial concentrations) or repeated instillations
over a long period of time to detect toxic effects [27,28,38],
which may be complex in animal models. A short duration of
testing, such as 14 or 28 days as used in standard toxicological
evaluations, at commercial concentrations in young healthy
animals may not reflect the clinical use when the drug is
administered over the long-term sometimes in association
with other drugs or preservative-containing eye drops or in
patients  with  preexisting  or  concomitant  ocular  surface
impairment.  This  point  raises  the  problem  of  validating
reliable tests for toxicological purposes and may explain why
clinical  trials  often  fail  to  show  mild  or  subclinical  toxic
effects that are observed in patients treated for long periods of
time, such as in glaucomatous patients in whom the ocular
surface has widely shown inflammatory changes and clinical
impairment [14-16,39-42].
Compared to the previous study by Ichijima [29], mainly
describing the effects on the superficial corneal epithelium,
we developed new in vivo tools and observed the entire ocular
surface, the cornea, the limbus, and the conjunctiva, at various
depths.  Moreover,  we  studied  inflammatory  markers  in
conjunctival imprints and confirmed this analysis by using
standard  immunohistology  after  animal  sacrifice.  This
approach  provides  much  broader  and  more  reliable
information than clinical assessment alone as in the standard
Draize test or even in investigations at the corneal level alone
as conjunctival inflammation may not be assessed by corneal-
based examinations. Moreover, this complementary set of
investigations decreases the need for large animal series as
IVCM  or  conjunctival  IC  may  be  used  repeatedly  for
monitoring drug toxicity or efficacy.
The toxicity ranking of the four eye drops tested in our
study was distributed as follows BAK Sol > BAK Em ≈CKC
Sol > CKC Em, this latter formulation being almost nontoxic
in  our  experimental  conditions.  Interestingly,  when
formulated in an emulsion, both BAK and CKC presented
reduced  toxicity  compared  to  the  same  concentration  in
solutions. This reduction of toxicity of BAK/CKC in emulsion
is attributed to the distribution of the QAC within the oil phase,
leading to a low concentration of QAC in the aqueous phase.
One of the proposed mechanisms of QAC for antimicrobial
activity is their intercalation within the bacterial membrane
[43]; in emulsion, they behave in a similar way by distributing
at the emulsion droplet surface. We therefore suggest that the
QAC that is bound to the emulsion surface is not available for
binding with bacterial membranes and that only the remaining
free QAC is responsible for the preservative effect and the
toxicity.  In  the  formulation  tested  in  the  present  study,
eventual toxicity was reduced not only by the use of cationic
emulsion but also by selecting a highly lipophilic QAC such
as  CKC  to  improve  the  compound  partition  within  the
emulsion. The lipophilicity of CKC partition is almost 100-
fold more important in octanol than in water, which is four to
five  times  higher  than  BAK.  Compared  to  BAK,  CKC
distributed  even  more  preferentially  into  the  oil  phase
(allowing  reduced  cationic  agent  content)  with  a  lesser
amount dissolved in the water phase and free for possible toxic
damage. Moreover, QAC could enhance membrane fluidity,
and CKC was found more efficient than BAK [44]. In our
experiments, CKC Em exhibited almost the same aspect as
the PBS-instilled group and did not induce any obvious ocular
toxicity during all the observation times. Consequently, CKC-
associated  emulsions  present  the  advantages  of  cationic
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213emulsions  and  reduced  free  QAC  and  demonstrated  no
obvious toxicity. Pharmaceutical companies require new in
vivo and in vitro tools to test the possible toxicity of their
newly  manufactured  drugs.  In  vivo  tests  present  the
advantages  of  mimicking  the  real  ocular  environment,
especially regarding the composition of the lachrymal film
and drug metabolism in ocular tissues. At the same time,
animal experimentation guidelines require refining the tests
to  reduce  the  number  of  animals  used.  In  addition  to
demonstrating  the  tolerance  of  emulsion-containing  eye
drops, this study has also proved that it is possible to refine
the  classical  scoring  elaborated  by  Draize  test,  based  on
clinical evaluations in 1944. However, as the gold standard in
ocular  toxicology,  it  lacks  precise  and  objective  criteria,
especially at cellular levels. The Draize test is therefore more
of  a  good  standard  for  eliminating  truly  toxic  drugs  in  a
screening approach than in a predictive evaluation of the real
use  of  eye  drops  in  further  clinical  development.  We
developed both the IVCM and flow cytometry on IC for our
toxicological models. Used in combination, each of these
techniques was able to detect and analyze the microstructures
Figure 8. Counts of positive cells for CD45 and TUNEL markers.
Counts  of  positive  cells  for  CD45  (A)  and  TUNEL  (B)  after
applications of PBS, BAK Sol, BAK Em, CKC Sol, or CKC Em at
D1 are displayed in this graph. The asterisk means that p<0.005
compared to PBS; the sharp (hash mark) indicates that p<0.005
compared to BAK Sol; and the double “S” symbol (§) denotes that
p<0.05 compared to CKC Em. A high level infiltration of CD45+
inflammatory cells and TUNEL+ apoptotic cells was found in the
limbus  and  conjunctiva,  especially  in  quaternary  ammonium
compounds  solution-receiving  eyes  compared  to  quaternary
ammonium compounds emulsion-instilled eyes.
of  the  animal’s  ocular  surface  (cornea,  limbus,  and
conjunctiva)  as  well  as  the  surface  markers  expressed  by
conjunctival  epithelium  in  toxic  conditions.  Based  upon
histological precise patterns of the ocular surface for three-
dimensional  visualization,  IVCM  offers  the  advantage  of
examining  the  same  animal  in  vivo  during  experimental
procedures  and  could  not  be  replaced  with  any  other
standardized method except histology after sacrifice, which
would have required a much higher number of animals to
provide successive time points. Moreover, specifically in the
rabbit model, IVCM also allows us to explore the limbus and
conjunctiva blood vessels that are difficult to see in small eyes
such  as  rat  eyes.  The  IVCM  scale  could  also  provide  a
classification of global toxicity in the cornea, limbus, and
conjunctiva. This scale system could be used as an effective
tool for evaluating ocular surface toxicity in a standardized
way in many laboratories worldwide.
Conjunctival IC also usefully completed the information
provided by IVCM. IC specimens were evaluated using a
standard  cytology  method  to  identify  the  different  cell
populations in the conjunctival epithelium and then using
FCM to assess the levels of inflammation or apoptosis. Thus,
IC specimens were also efficient ex vivo tools for evaluating
and comparing different toxic agents. As for human eyes
[45],  rabbit  conjunctival  imprints  collect  enough  cells  to
ensure reliable results obtained from FCM. In our study, RLA-
DR and TNFR1 were two inflammatory markers that were
found to be significantly increased after toxic injuries induced
by BAK Sol, confirming local inflammatory infiltration even
one day after instillation.
In this study, we proposed a set of tools for exploring a
drug’s toxicity in all components of the ocular surface, and
this set is more pertinent, complete, and reliable than if those
tools were used individually as in former studies. We also
showed that the use of long-chain CKC-cationic emulsions
should be further developed in eye drops because of their
reduced toxicity, the improvement in drug ocular delivery,
and finally for the comfort brought to patients.
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